Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EMR | Common Stock | Award | +2.08K | +29.52% | 9.11K | Nov 6, 2023 | Direct | F1, F2 | ||
transaction | EMR | Common Stock | Award | +5.85K | +64.19% | 15K | Nov 6, 2023 | Direct | F3, F4 | ||
transaction | EMR | Common Stock | Award | +10K | +66.87% | 25K | Nov 6, 2023 | Direct | F5, F6 |
Id | Content |
---|---|
F1 | Acquisition of 2,076 shares pursuant to Rule 16b-3 upon payout of 3,776 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2023. Of these 3,776 units, 2,076 units were paid in shares of Issuer stock, with the remaining 1,700 units paid in cash to cover the reporting person's tax obligations. |
F2 | Price is not applicable to the acquisitions described in Note 1. |
F3 | Grant to Reporting Person of 5,846 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
F4 | Price is not applicable to acquisitions resulting from grants of restricted stock units. |
F5 | Grant to Reporting Person of 10,000 shares of restricted stock under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
F6 | Price is not applicable to acquisitions resulting from grants of restricted stock. |